These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12792498)

  • 1. APC0576: a novel small molecule, immunosuppressive agent effective in primate models.
    Yuzawa K; Konishi A; Takehana K; Iino Y; Ohnuki A; Kobayashi T; Fukao K; Ohkohchi N
    Transplantation; 2003 May; 75(9):1463-8. PubMed ID: 12792498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APC0576, a novel inhibitor of NF-kappaB-dependent gene activation, prevents pro-inflammatory cytokine-induced chemokine production in human endothelial cells.
    Takehana K; Konishi A; Oonuki A; Noguchi M; Fujita K; Iino Y; Kobayashi T
    Biochem Biophys Res Commun; 2002 May; 293(3):945-52. PubMed ID: 12051750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APC0576 decreases production of pro-inflammatory chemokine and extracellular matrix by human Tenon's capsule fibroblasts.
    Naruse S; Yamada J; Hamuro J; Kobayashi T; Mori K; Kinoshita S
    Exp Eye Res; 2004 Aug; 79(2):223-30. PubMed ID: 15325569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo.
    Zhou WL; Wu JM; Wu QL; Wang JX; Zhou Y; Zhou R; He PL; Li XY; Yang YF; Zhang Y; Li Y; Zuo JP
    Acta Pharmacol Sin; 2005 Nov; 26(11):1352-8. PubMed ID: 16225758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model.
    Panzenbeck MJ; Jeanfavre DD; Kelly TA; Lemieux R; Nabozny G; Reilly PL; Desai S
    Eur J Pharmacol; 2006 Mar; 534(1-3):233-40. PubMed ID: 16487962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo.
    Zhu YN; Zhao WM; Yang YF; Liu QF; Zhou Y; Tian J; Ni J; Fu YF; Zhong XG; Tang W; Zhou R; He PL; Li XY; Zuo JP
    J Pharmacol Exp Ther; 2006 Feb; 316(2):662-9. PubMed ID: 16204471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
    Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.
    Wang JX; Tang W; Yang ZS; Wan J; Shi LP; Zhang Y; Zhou R; Ni J; Hou LF; Zhou Y; He PL; Yang YF; Li Y; Zuo JP
    Eur J Pharmacol; 2007 Jun; 564(1-3):211-8. PubMed ID: 17349993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production.
    Yun CH; Son CG; Jung U; Han SH
    Toxicology; 2006 Jan; 217(1):31-8. PubMed ID: 16168555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo.
    Zhou R; Zhang F; He PL; Zhou WL; Wu QL; Xu JY; Zhou Y; Tang W; Li XY; Yang YF; Li YC; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1895-903. PubMed ID: 16275624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl)ethyl]propenamide (Z23), an effective compound from the Chinese herb medicine Fissistigma oldhamii (Hemsl.) Merr, suppresses T cell-mediated immunity in vitro and in vivo.
    Hu XD; Zhong XG; Zhang XH; Zhang YN; Zheng ZP; Zhou Y; Tang W; Yang Y; Yang YF; Hu LH; Zuo JP
    Life Sci; 2007 Dec; 81(25-26):1677-84. PubMed ID: 18022200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
    Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
    J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT20126, a novel immunosuppressant, prevents collagen-induced arthritis through the down-regulation of inflammatory gene expression by inhibiting NF-kappaB activation.
    Lee SJ; Nam WD; Na HJ; Cho YL; Ha KS; Hwang JY; Lee H; Kim SO; Kwon YG; Kim YM
    Biochem Pharmacol; 2008 Jul; 76(1):79-90. PubMed ID: 18513703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new NF-kappaB inhibitor attenuates a TH1 type immune response in a murine model.
    Kabashima K; Honda T; Nunokawa Y; Miyachi Y
    FEBS Lett; 2004 Dec; 578(1-2):36-40. PubMed ID: 15581612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the immunosuppressive properties of Sch 24937.
    Smith SR; Terminelli C; Epps S; Watnick A; Umland S
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):333-59. PubMed ID: 2963854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of electroacupuncture on TH1/TH2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic T cells of traumatized rats.
    Wang K; Wu H; Wang G; Li M; Zhang Z; Gu G
    Anesth Analg; 2009 Nov; 109(5):1666-73. PubMed ID: 19843806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
    Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
    Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes.
    Zhu B; Liu Z; Wang P; Wu C; Xu H
    Transplant Proc; 2008 Oct; 40(8):2724-8. PubMed ID: 18929846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.
    Leiba M; Cahalon L; Shimoni A; Lider O; Zanin-Zhorov A; Hecht I; Sela U; Vlodavsky I; Nagler A
    J Leukoc Biol; 2006 Aug; 80(2):399-406. PubMed ID: 16769768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new carboxamide compound exerts immuno-suppressive activity by inhibiting dendritic cell maturation.
    Carbonnelle D; Ebstein F; Rabu C; Petit JY; Gregoire M; Lang F
    Eur J Immunol; 2005 Feb; 35(2):546-56. PubMed ID: 15668915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.